"X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies..."  hit headlines earlier in April on an international level.  Headlines however ostensibly in sector framework.  In other words, unless you were looking for news of that subject, it might have been hard to find.

Version of the article located at   and  starts out with "WALTHAM, Mass. and LIANYUNGANG, China, Apr...
Continue reading ...